Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers.

J Control Release 2012 Jul 23;161(2):554-65. Epub 2011 Nov 23.

Pharmaceutical Biotechnology, Center for System-based Drug Research, and Center for NanoScience, Ludwig-Maximilians-Universit├Ąt, Butenandtstrasse 5-13, 81377 Munich, Germany.

Gene therapy offers great opportunities for the treatment of severe diseases including cancer. In recent years the design of synthetic carriers for nucleic acid delivery has become a research field of increasing interest. Studies on the delivery of plasmid DNA (pDNA) have brought up a variety of gene delivery vehicles. The more recently emerged gene silencing strategy by the intracellular delivery of small interfering RNA (siRNA) takes benefit from existing expertise in pDNA transfer. Despite common properties however, delivery of siRNA also faces distinct challenges due to apparent differences in size, stability of the formed nucleic acid complexes, the location and mechanism of action. This review emphasizes the common aspects and main differences between pDNA and siRNA delivery, taking into consideration a wide spectrum of polymer-based, lipidic and peptide carriers. Challenges and opportunities which result from these differences as well as the recent progress made in the optimization of carrier design are presented.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2011.11.014DOI Listing
July 2012

Publication Analysis

Top Keywords

nucleic acid
8
synthetic carriers
8
plasmid dna
8
sirna delivery
8
delivery
7
despite common
4
common properties
4
differences size
4
transfer despite
4
pdna transfer
4
size stability
4
properties delivery
4
delivery sirna
4
distinct challenges
4
challenges apparent
4
faces distinct
4
expertise pdna
4
sirna faces
4
apparent differences
4
benefit existing
4

Similar Publications